Homoharringtonine for injection
Indication
This product is an anti-tumor drug. It is suitable for the induction remission and continued treatment stages of various types of acute non-lymphocytic leukemia, especially for acute promyelocytic leukemia, acute monocytic leukemia, and acute granulocytic leukemia. It also has a certain effect on myelodysplastic syndrome (MDS), chronic myeloid leukemia and polycythemia vera.
Packaging Specification
1mg
Manufacturer
Xi'an Disai Biopharmaceutical Co., Ltd.
-
Founded in:
2000-01-11 -
Address:
No. 69, Hongmiaopo, Lianhu District, Xi'an -
Tax NO.:
91610104710178671F -
Registered Funds:
65 million yuan -
Website:
-
Email: